Evidence map›Paper›PMID 37527470›Full record

ArticleThe Journal of infectious diseases2024

Predictors of Severity of Influenza-Related Hospitalizations: Results From the Global Influenza Hospital Surveillance Network (GIHSN).

Lily E Cohen, Chelsea L Hansen, Melissa K Andrew, Shelly A McNeil, Philippe Vanhems, Jan Kyncl, Javier Díez Domingo, Tao Zhang, Ghassan Dbaibo, Victor Alberto Laguna-Torres and 19 more

Open access · greenAbstract read
In one paragraph

Article in The Journal of infectious diseases, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Severity of Clinical Presentation and Outcomes in Hospitalized Adult People With Influenza by Type and Subtype, United States-2017-2020.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 20 institutions in 22 countries.

Lily E CohenReady2Respond p/o The Task Force for Global Health, Decatur, Georgia, USA.ORCID 0000-0002-2207-8330
Chelsea L HansenDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, USA.
Melissa K AndrewCanadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health, Dalhousie University, Halifax, Nova Scotia, Canada.
Shelly A McNeilCanadian Center for Vaccinology, IWK Health Centre and Nova Scotia Health, Dalhousie University, Halifax, Nova Scotia, Canada.
Philippe VanhemsHôpital Edouard Herriot, Lyon, France.
Jan KynclDepartment of Infectious Diseases Epidemiology, National Institute of Public Health, Prague, Czech Republic.
Javier Díez DomingoFundación Para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana (FISABIO-Public Health), Valencia, Spain.
Tao ZhangSchool of Public Health, Fudan University, Shanghai, China.
Ghassan DbaiboCenter for Infectious Diseases Research, American University of Beirut, Beirut, Lebanon.
Victor Alberto Laguna-TorresClínica Internacional, Instituto de Medicina Tropical Universidad Nacional Mayor de San Marcos, Lima, Peru.
Anca DraganescuNational Institute for Infectious Diseases "Prof Dr Matei Bals", Bucharest, Romania.
Elsa BaumeisterRespiratory Virus Laboratory, Virology Department, INEI-ANLIS, Buenos Aires, Argentina.
Doris GomezGrupo de Investigación UNIMOL, Facultad de Medicina, Universidad de Cartagena, Cartagena de Indias, Colombia.
Sonia M RaboniVirology Laboratory, Infectious Diseases Division, Universidade Federal do Paraná, Hospital Pequeno Principe, Curitiba, Paraná, Brazil.
Heloisa I G GiamberardinoVirology Laboratory, Infectious Diseases Division, Universidade Federal do Paraná, Hospital Pequeno Principe, Curitiba, Paraná, Brazil.
Marta C NunesSouth African Medical Research Council, Vaccines and Infectious Diseases Analytics Research Unit, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
Elena BurtsevaGamaleya Federal Research Center for Epidemiology and Microbiology, Ministry of Health of Russian Federation, Moscow, Russia.
Anna SomininaSmorodintsev Research Institute of Influenza, St Petersburg, Russia.
Snežana MedićInstitute for Public Health of Vojvodina, Novi Sad, Serbia.
Daouda CoulibalyNational Institute of Public Hygiene, Abidjan, Côte d'Ivoire.
Afif Ben SalahInstitut Pasteur de Tunis, Tunis, Tunisia.
Nancy A OtienoKenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Parvaiz A KoulSheri Kashmir Institute of Medical Sciences, Srinagar, India.
Serhat UnalDepartment of Infectious Diseases and Clinical Microbiology, Hacettepe University School of Medicine, Ankara, Turkey.
Mine Durusu TanrioverTurkish Society of Internal Medicine, Ankara, Turkey.
Marie MazurReady2Respond p/o The Task Force for Global Health, Decatur, Georgia, USA.
Joseph BreseeReady2Respond p/o The Task Force for Global Health, Decatur, Georgia, USA.
Cecile ViboudDivision of International Epidemiology and Population Studies, Fogarty International Center, National Institutes of Health, Bethesda, Maryland, USA.
Sandra S ChavesFoundation for Influenza Epidemiology, Fondation de France, Paris, France.
The Task Force for Global Health · USDalhousie University · CATurkish Society of Cardiology · TRUniversidade Federal do Paraná · BRAdministración Nacional de Laboratorios e Institutos de Salud · ARAmerican University of Beirut · LBCharles University · CZFondation de France · FRFudan University · CNFundación para el Fomento de la Investigación Sanitaria y Biomédica de la Comunitat Valenciana · ESHôpital Edouard Herriot · FRInstitut National d’Hygiène Publique · CIInstitut Pasteur de Tunis · TNKenya Medical Research Institute · KEMinistry of Health of the Russian Federation · RUNational Institute of Research and Development for Biological Sciences · RONational Institutes of Health · USNational University of San Marcos · PEResearch Institute of Influenza · RURoskilde University · DK

Funding

Wellcome TrustWellcome Trust 224690/Z/21/Z
6 · The paper itself

Abstract

backgroundThe Global Influenza Hospital Surveillance Network (GIHSN) has since 2012 provided patient-level data on severe influenza-like-illnesses from >100 participating clinical sites worldwide based on a core protocol and consistent case definitions.

methodsWe used multivariable logistic regression to assess the risk of intensive care unit admission, mechanical ventilation, and in-hospital death among hospitalized patients with influenza and explored the role of patient-level covariates and country income level.

resultsThe data set included 73 121 patients hospitalized with respiratory illness in 22 countries, including 15 660 with laboratory-confirmed influenza. After adjusting for patient-level covariates we found a 7-fold increase in the risk of influenza-related intensive care unit admission in lower middle-income countries (LMICs), compared with high-income countries (P = .01). The risk of mechanical ventilation and in-hospital death also increased by 4-fold in LMICs, though these differences were not statistically significant. We also find that influenza mortality increased significantly with older age and number of comorbid conditions. Across all severity outcomes studied and after controlling for patient characteristics, infection with influenza A/H1N1pdm09 was more severe than with A/H3N2.

conclusionsOur study provides new information on influenza severity in underresourced populations, particularly those in LMICs.

Indexed as

Influenza, HumanHospitalizationHospital MortalityHospitalsHumansInfluenza A Virus, H3N2 Subtypedisease severityglobal healthinfluenza epidemiologylower middle-income countriessurveillance

Identifiers

PMID37527470
PMCPMC11011157
OpenAlexW4385450268

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.